We are live on ! Find out more
QTTB icon

Q32 Bio

53 hedge funds and large institutions have $16.6M invested in Q32 Bio in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more capital invested

Capital invested by funds: $13.4M → $16.6M (+$3.28M)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

4.51% less ownership

Funds ownership: 73.61%69.1% (-4.5%)

13% less funds holding

Funds holding: 6153 (-8)

44% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 18

50% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 16

Holders
53
Holders Change
-8
Holders Change %
-13.11%
% of All Funds
0.7%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
8
Increased
10
Reduced
18
Closed
16
Calls
Puts
Net Calls
Net Calls Change

QTTB Hedge Fund Activity: Q3 2025 in Review

53 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q3 2025, worth a combined $16.6M — up 25% from $13.4M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of QTTB and 8 opened new positions — a net loss of 8 holders — while 18 trimmed existing stakes and 10 added.

The largest buyer was Two Sigma Investments, opening a new position worth an estimated $60.5K. The largest seller was Monaco Asset Management, cutting an estimated $540K.

  • 53 institutional investors held Q32 Bio (QTTB) as of Q3 2025, down from 61 in Q2 2025.
  • Funds reported $16.6M of Q32 Bio stock for Q3 2025, up 25% quarter-over-quarter.
  • 8 funds opened new Q32 Bio positions in Q3 2025 and 16 closed out, a net change of -8 holders.
  • The largest Q32 Bio buyer in Q3 2025 was Two Sigma Investments, an estimated $60.5K added.
  • The largest Q32 Bio seller in Q3 2025 was Monaco Asset Management, an estimated $540K sold.

Based on aggregated 13F filings for Q3 2025.